Works matching AU Johnson, Melissa


Results: 283
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-024-55316-5
    By:
    • Gounder, Mrinal;
    • Johnson, Melissa;
    • Heist, Rebecca S.;
    • Shapiro, Geoffrey I.;
    • Postel-Vinay, Sophie;
    • Wilson, Frederick H.;
    • Garralda, Elena;
    • Wulf, Gerburg;
    • Almon, Caroline;
    • Nabhan, Salah;
    • Aguado-Fraile, Elia;
    • He, Peng;
    • Romagnoli, Mathilde;
    • Hossain, Mohammad;
    • Narayanaswamy, Rohini;
    • Sadou-Dubourgnoux, Amel;
    • Cooper, Michael;
    • Askoxylakis, Vasileios;
    • Burris, Howard A.;
    • Tabernero, Josep
    Publication type:
    Article
    20
    21
    22
    23
    24

    Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy

    Published in:
    Pharmacotherapy, 2024, v. 44, n. 5, p. 360, doi. 10.1002/phar.2914
    By:
    • Cluck, David B.;
    • Chastain, Daniel B.;
    • Murray, Milena;
    • Durham, Spencer H.;
    • Chahine, Elias B.;
    • Derrick, Caroline;
    • Dumond, Julie B.;
    • Hester, E. Kelly;
    • Jeter, Sarah B.;
    • Johnson, Melissa D.;
    • Kilcrease, Christin;
    • Kufel, Wesley D.;
    • Kwong, Jeffrey;
    • Ladak, Amber F.;
    • Patel, Nimish;
    • Pérez, Sarah E.;
    • Poe, Jonell B.;
    • Bolch, Charlotte;
    • Thomas, Ian;
    • Asiago‐Reddy, Elizabeth
    Publication type:
    Article
    25

    Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary

    Published in:
    Pharmacotherapy, 2024, v. 44, n. 5, p. 354, doi. 10.1002/phar.2913
    By:
    • Cluck, David B.;
    • Chastain, Daniel B.;
    • Murray, Milena;
    • Durham, Spencer H.;
    • Chahine, Elias B.;
    • Derrick, Caroline;
    • Dumond, Julie B.;
    • Hester, E. Kelly;
    • Jeter, Sarah B.;
    • Johnson, Melissa D.;
    • Kilcrease, Christin;
    • Kufel, Wesley D.;
    • Kwong, Jeffrey;
    • Ladak, Amber F.;
    • Patel, Nimish;
    • Pérez, Sarah E.;
    • Poe, Jonell B.;
    • Bolch, Charlotte;
    • Thomas, Ian;
    • Asiago‐Reddy, Elizabeth
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    37
    38
    39

    Antibiotic Myths for the Infectious Diseases Clinician.

    Published in:
    Clinical Infectious Diseases, 2023, v. 77, n. 8, p. 1120, doi. 10.1093/cid/ciad357
    By:
    • McCreary, Erin K;
    • Johnson, Melissa D;
    • Jones, Travis M;
    • Spires, S Shaefer;
    • Davis, Angelina E;
    • Dyer, April P;
    • Ashley, Elizabeth Dodds;
    • Gallagher, Jason C
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46

    Dada's Women.

    Published in:
    2011
    By:
    • Johnson, Melissa
    Publication type:
    Book Review
    47
    48

    CX3CR1-dependent renal macrophage survival promotes Candida control and host survival.

    Published in:
    2013
    By:
    • Lionakis, Michail S;
    • Swamydas, Muthulekha;
    • Fischer, Brett G;
    • Plantinga, Theo S;
    • Johnson, Melissa D;
    • Jaeger, Martin;
    • Green, Nathaniel M;
    • Masedunskas, Andrius;
    • Weigert, Roberto;
    • Mikelis, Constantinos;
    • Wan, Wuzhou;
    • Lee, Chyi-Chia Richard;
    • Lim, Jean K;
    • Rivollier, Aymeric;
    • Yang, John C;
    • Laird, Greg M;
    • Wheeler, Robert T;
    • Alexander, Barbara D;
    • Perfect, John R;
    • Gao, Ji-Liang
    Publication type:
    journal article
    49

    CX<sub>3</sub>CR1-dependent renal macrophage survival promotes Candida control and host survival.

    Published in:
    Journal of Clinical Investigation, 2013, v. 123, n. 12, p. 5035, doi. 10.1172/JCI71307
    By:
    • Lionakis, Michail S.;
    • Swamydas, Muthulekha;
    • Fischer, Brett G.;
    • Plantinga, Theo S.;
    • Johnson, Melissa D.;
    • Jaeger, Martin;
    • Green, Nathaniel M.;
    • Masedunskas, Andrius;
    • Weigert, Roberto;
    • Mikelis, Constantinos;
    • Wuzhou Wan;
    • Chyi-Chia Richard Lee;
    • Jean K. Lim;
    • Rivollier, Aymeric;
    • John C. Yang;
    • Laird, Greg M.;
    • Wheeler, Robert T.;
    • Alexander, Barbara D.;
    • Perfect, John R.;
    • Ji-Liang Gao
    Publication type:
    Article
    50

    The Salafia method rediscovered.

    Published in:
    Virchows Archiv: European Journal of Pathology, 2009, v. 454, n. 3, p. 355, doi. 10.1007/s00428-009-0738-6
    By:
    • Dario Piombino-Mascali;
    • Arthur Aufderheide;
    • Melissa Johnson-Williams;
    • Albert Zink
    Publication type:
    Article